Cefuni Tablet (Cefpodoxime Proxetil)

Adult dosage

Adults: Administer 100mg (potency) of cefpodoxime orally twice daily after meals. If the infection is severe or the response is considered inadequate, administer 200mg (potency) orally twice daily after meals. The dosage may be adjusted as appropriate according to age, symptoms, etc.

This drug should not be used in patients who have experienced severe allergic reactions or shock from this medication in the past. Since this drug contains lactose, it should not be administered to patients with a genetic disorder that prevents them from digesting lactose. Patients with a history of allergy to this drug's ingredients or similar class antibiotics should avoid use unless necessary, and must use it very carefully when it is essential. Patients allergic to penicillin antibiotics should exercise caution when using this medication. Patients with a family history of allergies such as bronchial asthma, skin rashes, or urticaria should use this drug with caution. Patients with severely impaired renal function may experience delayed elimination of this drug, necessitating careful administration. Patients who have difficulty swallowing the drug orally, are receiving parenteral nutrition, elderly patients, and those in a poor overall condition should be closely monitored for symptoms of Vitamin K deficiency. This drug can rarely cause severe reactions such as shock or anaphylaxis, hence the patient's condition should be carefully monitored during administration. If skin rashes, urticaria, itching, or fever appears, administration should be stopped immediately, and appropriate treatment should be administered. Gastrointestinal side effects such as severe colitis, abdominal pain, or diarrhea may occur; if these symptoms appear, the medication should be discontinued immediately. If symptoms of dyspnea, coughing, or pneumonia develop, administration should be stopped and appropriate treatment is needed. Blood tests may reveal abnormalities such as thrombocytopenia or leukopenia, hence regular blood tests are necessary during prolonged administration. Neurological symptoms such as altered consciousness or seizures may occur, especially in patients with impaired renal function, thus dosage adjustment is crucial. Rarely, serious skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, necessitating careful observation of the skin condition. Liver function abnormalities may appear, so liver function tests may also be necessary. Renal function abnormalities may occur, necessitating regular renal function tests. Microbial flora shift can cause oral conditions such as stomatitis or candidiasis, so oral condition should also be monitored carefully. Symptoms of bleeding tendency may appear due to Vitamin K deficiency, thus attention to bleeding symptoms is required. This medication should be used only for the minimum necessary duration to prevent the emergence of antibiotic-resistant bacteria. To prevent shock reactions, it is advisable to check the patient's allergic history and perform skin reaction tests before administration. Dizziness may occur during administration; thus caution is advised when driving or operating machinery. If used for more than 10 days, blood tests should be conducted to check for neutrophil levels. For patients with reduced renal function, careful dosage adjustment is critical; administration should be discontinued if seizures occur. This drug may burden the kidneys when used in conjunction with diuretics or certain antibiotics, thus it should be closely monitored when combined. Additionally, changes in serum concentration may occur due to interactions with other medications, so caution is necessary when taking medications concurrently. Safety during pregnancy has not been established, and women of childbearing potential should use this drug only when the benefits outweigh the risks. Women who are breastfeeding should ideally discontinue breastfeeding, as this drug may be passed into breast milk. Caution is necessary in children, especially in newborns or premature infants, as safety has not been fully established. Elderly patients may have decreased physical function and higher bleeding risks; hence careful dosage and interval adjustments and monitoring of their condition are necessary. This drug may affect the results of some clinical tests, so caution is needed when interpreting test results.

shock

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is important to maintain a room temperature between 1 degree and 30 degrees Celsius when storing the medication. This will help to preserve the effectiveness of the drug for a long time.

Appearance

White round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle